Tokyo, Japan

Hiroyuki Kakinuma

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 51(Granted Patents)


Location History:

  • Tokyo, JP (2007 - 2011)
  • Toshima-ku, JP (2011 - 2015)

Company Filing History:


Years Active: 2007-2015

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Introduction

Hiroyuki Kakinuma is a notable inventor based in Tokyo, Japan, recognized for his significant contributions to the field of pharmaceuticals, particularly in diabetes treatment. With a robust portfolio of 10 patents, Kakinuma's work focuses on innovative compounds that can enhance glucose control in patients with diabetes.

Latest Patents

Among Kakinuma's latest inventions are two remarkable patents that involve 4-isopropyl-6-methoxyphenyl glucitol compounds. These compounds are designed to inhibit SGLT1 (sodium-dependent glucose transporter 1) activity, which plays a critical role in glucose absorption. By suppressing this activity, the compounds aim to improve abnormal glucose tolerance and counteract postprandial hyperglycemia in diabetes patients. Another significant patent features 4-isopropylphenyl glucitol compounds that also operate as SGLT1 inhibitors, ensuring minimal accumulation in the body while effectively managing glucose absorption. These advancements have the potential to not only prevent diabetes but also treat related conditions such as metabolic syndrome.

Career Highlights

Hiroyuki Kakinuma is currently affiliated with Taisho Pharmaceutical Co., Ltd., a company characterized by its commitment to pharmaceutical innovation. His extensive research and patent development reflect his dedication to enhancing therapeutic options for diabetes care, showcasing his role as a leader in the pharmaceutical field.

Collaborations

Throughout his career, Kakinuma has collaborated with talented individuals like Takahiro Oi and Masakazu Sato. Their collective efforts have facilitated the advancement of groundbreaking innovations in diabetes treatment, positioning the team as pioneers in their domain.

Conclusion

Hiroyuki Kakinuma's contributions to the pharmaceutical industry through his patents and collaborative projects underline his importance as an inventor. With a focus on improving healthcare outcomes for diabetes patients, his work continues to pave the way for future innovations aimed at managing this widespread condition effectively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…